Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07444905
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years.
* Diagnosis of hepatocellular carcinoma (HCC) confirmed by histopathology or accepted radiologic criteria per international guidelines.
* No evidence of extrahepatic metastasis at baseline evaluation.
* Receiving standard-of-care management with planned longitudinal follow-up in routine clinical practice.
* Availability of baseline clinical and imaging data required for risk assessment using the pre-specified machine learning model.
* Ability to provide written informed consent, or inclusion under ethics committee-approved procedures.
Exclusion Criteria:
* Confirmed extrahepatic metastasis at enrollment (baseline).
* History of other active malignancy within the past 5 years, except adequately treated non-melanoma skin cancer or in situ carcinoma.
* Incomplete baseline clinical information that precludes model-based risk assessment.
* Expected survival \< 3 months due to severe comorbidities.
* Participation in an interventional clinical trial that may substantially alter follow-up strategy or metastasis assessment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT07444905
Study Brief:
Protocol Section:
NCT07444905